Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADVATE in pediatric hemophilia A (Study 060401)
NCT00189982Phase 3Completed
- Sponsor
- Takeda
- Start
- Dec 2004
- Primary completion
- Nov 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human coagulation factor VIII in hemophilia A, sponsored by Takeda. Started Dec 2004; status: completed.
02
Drugs
recombinant human coagulation factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT00189982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00189982.